Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults with rheumatoid arthritis based on EULAR ACR score greater than 6 by10 Patients with moderate DAS score 3 point 2 to 5 point 1 Patients who are willing to attend OPD or willing for admission in IPD Patients who are willing to undergo Radiological investigation and other laboratory investigation Patient who are willing to sign the informed consent stating that he she will consciously stick to the treatment during 75 days but can stop opt out of the trail of his her own conscious discretion
Exclusion criteria
Exclusion criteria: Pregnancy and lactating mother Hypothyroidism and hyperthyroidism Uncontrolled Hypertension greater than 180 by 110 mm Hg Liver disease Neurological disease Recent treatment with steroids before 3 months Uncontrolled Diabetes mellitus HbA1c greater than 8 point 2 percentage Known case of Any other arthritis History of trauma Extra articular involvement of Rheumatoid arthritis except anemia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be Reduction of pain and swelling of the joints, Improvement in the movement of affected joints, and Reduction of disability DAS SCALETimepoint: 4 months screening 2 months recruiting 2 month data collection 6 month treatment period 4 month data analysis | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in the quality of life Qualisex questionnaire Anti inflammatory effect of vadha kesari thylam will be assessed by in vitro Cox inhibition assayTimepoint: 2 months for lab work 2 months for data analysi | — |
Countries
India
Contacts
National Institute of Siddha